Together, this study demonstrates for the first time that neferine has therapeutic prospect for targeting IMR32 human neuroblastoma cells through the best fit in the binding pocket of FAK and S6K1 proteins, and caused decrease the level of these two proteins. Here, RPS6KB1 is linked to neuroblastoma.